On or around 04/07/2000 (Date of order of final judgment)
Filing Date: March 16, 1998
According to the Judgment, entered on April 7, 2000, U.S. District Judge Loretta A. Preska granted defendants’ motion to dismiss the First Amended and Consolidated Complaint with prejudice in its entirety. The case was closed.
The original complaint alleges that Ultrafem and certain of its officers and directors violated Sections 11, 12, and 15 of the Securities Act of 1933 and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by misrepresenting and/or omitting material information concerning the company's business and revenues, including information about problems with the sales of the company's main product, Instead.
Company & Securities Information
Defendant: Ultrafem, Inc.
Industry: Medical Equipment & Supplies
Headquarters: United States
Ticker Symbol: UFEM
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.